Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study

200979 citationsJournal Articlebronze Open Access

Authors

Jean‐Jacques Wyndaele · Universitair Ziekenhuis Leuven

Evan R. Goldfischer · Hudson Dermatology

Jon D. Morrow · Pfizer (United States)

Jinxia Gong · Pfizer (United States)

Li‐Jung Tseng · Pfizer (United States)

Zhiwei Guan · Pfizer (United States)

Myung‐Soo Choo ·

Abstract

Flexible-dose fesoterodine significantly improved OAB symptoms, HRQL, and rates of treatment satisfaction and was well tolerated in subjects with OAB who were dissatisfied with prior tolterodine therapy.

Topics & Keywords

Urinary Bladder and Prostate Research Pelvic floor disorders treatments Urological Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Clinical Practice

Volume 63, Issue 4, pp. 560-567

DOI: 10.1111/j.1742-1241.2009.02035.x

Field-Weighted Citation Impact: 11.44